Navigation Links
ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss
Date:3/3/2010

SAN CLEMENTE, Calif., March 3 /PRNewswire/ -- ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss.  The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery. The ReShape device occupies existing space in the stomach to reduce its capacity for food.  The balloons remain in place for six-months and are then removed.

The first U.S. study participant received the ReShape Balloons Treatment at The N.E.W. Program in Newport Beach, Calif., under the care of Brian Quebbemann, M.D., FACS, and Surgical Director of The N.E.W. Program.  "At 6'2" and 263 pounds, this 31-year old man did not qualify for bariatric surgery, and had exhausted his efforts with diets that didn't work," said Dr. Quebbemann.  


'/>"/>
SOURCE ReShape Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Calif., Feb. 27, 2015 Isis Pharmaceuticals, Inc. ... outperformed both its pro forma net operating loss (NOL) ... a strong financial position.  Isis, significantly improved financial results ... $230 million in payments the Company received from its ... 2014 was a nearly 60% improvement over its 2013 ...
(Date:2/27/2015)... N.J. , Feb. 27, 2015 An ... has helped cut the rate of infection with a ... 40 percent. Clostridium difficile, or C.diff, is ... to life-threatening inflammation of the colon. A recent article ... of Clostridium difficile Infection in the United ...
(Date:2/27/2015)... -- Report Details   Translational ... progress, and predicted revenues ,Where is the market for ... prospects for this market and related technologies? Visiongain,s brand ... to 2025, discussing data, opportunities and prospects. ... medicine : cell-based therapies that aim to restore function ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... , ABBOTT PARK, Ill., Feb. 11 Abbott ... and Drug Administration (FDA) has granted approval of a new tablet ... Norvir tablets can be stored at room temperature and ... Norvir tablets and the Norvir soft-gelatin capsules both contain 100 mg ...
... , , HONG KONG , Feb. ... been enrolled in a randomized clinical trial of the Genous Bio-engineered ... study, the trial will enroll 180 patients split evenly between the ... primary study objective is to demonstrate the safety and effectiveness of ...
Cached Medicine Technology:Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 2Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 3Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 4Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 5Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 6Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 7Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 8Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 9Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 10Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 11Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 12Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 13OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China 2OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China 3
(Date:2/27/2015)... On February 24 2015, Harper’s Bazaar Magazine ... ,” that details the development of RT001, a form of ... through FDA trials. For those afraid of needles, the idea ... Of course, if the drug ultimately gets FDA approval it ... (see: goo.gl/PQvQwk) , “As the article notes, the size of ...
(Date:2/27/2015)... The winter season is here, and with it comes an ... can be harmful to the home and to one’s health. ... growth with the help of Enviro-Test. Enviro-Test, the mold removal ... ways to prevent mold during the winter months. , Winter ... to thrive. Mold must be removed properly, otherwise there is ...
(Date:2/27/2015)... Florida Hospital North Pinellas is being recognized as a ... In order to receive the award, Florida Hospital North ... With The Guidelines - Stroke Quality Achievement indicators for ... or higher compliance with six of 10 Get With ... initiatives to measure quality of care. , ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The ... has announced a scholarship for rising freshmen undergraduate students. ... leading periodontist office specializing in many periodontal procedures such ... treatment of gum disease . In honor of ... college scholarship for eligible rising freshmen undergraduate students. ...
(Date:2/27/2015)... FL (PRWEB) February 27, 2015 ... testing company that provides vascular, echocardiogram and NCV ... to be the preferred diagnostic testing provider for ... a coeducational public liberal arts university in Milledgeville, ... the Wimbledon U collegiate division, include ...
Breaking Medicine News(10 mins):Health News:Is Topical Botox the Next Big Thing? 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 3
... Mo., Jan. 5 The recent tragic death of Jett ... which he was diagnosed in early childhood. Kawasaki disease is ... the age of five. The disease occurs more often in ... and Korean descent. Although most children diagnosed with Kawasaki recover ...
... Despite a deepening recession, only eight percent of hospital ... year than in 2008 said their institutions would have ... and underinsured, according to a new survey issued today ... overwhelming majority of AHP members surveyed said they will ...
... CHESHIRE, Conn., Jan. 5 Alexion Pharmaceuticals, Inc. (Nasdaq: ... Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present ... San Francisco at 4:30 p.m. local time (7:30 p.m. ... Dr. Bell,s remarks will be available live. You can ...
... Malaria Prevention Campaign has crossed the 50 countries threshold. Over ... broadcasters, non-governmental organizations, youth groups, universities, schools and hospitals. , ... ... and Bite Malaria Prevention Campaign has crossed the 50 countries threshold. ...
... CHICAGO, Jan. 5 Continuing its efforts to,educate, inform, ... a not-,for-profit patient-focused organization, is hosting its 25-minute live ... on Monday,January 12, 2009 at 6:00 PM on Channel ... feature an intimate discussion with Dr. Arthur Dorf,Eye Physician ...
... and REDMOND, Wash., Jan. 5 Microsoft,Health Users Group ... entries for the Microsoft HUG 2009 Innovation Awards. The ... solution partner,recognizes leadership in the use of technology to ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO ) , ...
Cached Medicine News:Health News:Jett Travolta and Kawasaki Disease: Separating Fact From Fiction 2Health News:AHP Recession Survey of Nonprofit Health Care Officials Finds Almost Half Expect Reduced Giving in 2009, Leading to Cuts in Hospital Construction and Equipment Purchases 2Health News:The Buzz And Bite Malaria Prevention Campaign Is In Use In 50 Countries 2Health News:The Buzz And Bite Malaria Prevention Campaign Is In Use In 50 Countries 3Health News:For Your Eyes Only - How to Choose and Use Your Eye Doctor 2Health News:Microsoft HUG 2009 Innovation Awards Call for Entries Now Open 2Health News:Microsoft HUG 2009 Innovation Awards Call for Entries Now Open 3
... The CMGS-1 Color Mini-Ganzfeld Stimulator is ... can be integrated with your existing LKC ... with other visual electrodiagnostic test systems. ... is the smallest commercial Ganzfeld to meet ...
... the most advanced visual electrodiagnostic system ... of retinal and optic nerve function. ... drives this powerful computer-controlled instrument. With ... pattern stimulation, rapid Ganzfeld flash rate ...
... designed to facilitate an arthrodesis, either by ... interbody cages allowing radicular compression by restoring ... and of the foramina, which in turn ... for major lumbar instabilities.,CC cages are made ...
... SHELLGEL is a sterile nonpyrogenic, transparent ... SHELLGEL contains 12 mg/mL of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: